BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.
Henssen A, Thor T, Odersky A, Heukamp L, El-Hindy N, Beckers A, Speleman F, Althoff K, Schäfers S, Schramm A, Sure U, Fleischhack G, Eggert A, Schulte JH.
Henssen A, et al. Among authors: sure u.
Oncotarget. 2013 Nov;4(11):2080-95. doi: 10.18632/oncotarget.1534.
Oncotarget. 2013.
PMID: 24231268
Free PMC article.